Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIA Breast Cancer AJCC v6 and v7”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Study completedNCT02654119
What this trial is testing

Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery

Who this might be right for
HER2 Positive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
University of Nebraska 20
Large-scale testing (Phase 3)Active Not RecruitingNCT00310180
What this trial is testing

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Who this might be right for
Breast AdenocarcinomaHormone Receptor PositiveStage IA Breast Cancer AJCC v7+4 more
National Cancer Institute (NCI) 10,273
Large-scale testing (Phase 3)Study completedNCT00770809
What this trial is testing

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Male Breast CarcinomaStage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7+3 more
National Cancer Institute (NCI) 305
Testing effectiveness (Phase 2)Active Not RecruitingNCT03012100
What this trial is testing

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Bilateral Breast CarcinomaBreast Inflammatory CarcinomaStage IB Breast Cancer AJCC v7+9 more
Academic and Community Cancer Research United 280
Large-scale testing (Phase 3)Study completedNCT00005970
What this trial is testing

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaHER2 Positive Breast CarcinomaStage IA Breast Cancer AJCC v7+4 more
National Cancer Institute (NCI) 3,436
Testing effectiveness (Phase 2)Study completedNCT03477396
What this trial is testing

Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor and/or Progesterone Receptor PositiveHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7
City of Hope Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT02593175
What this trial is testing

Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC

Who this might be right for
Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+8 more
M.D. Anderson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT03454529
What this trial is testing

The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
Michael Simon 24
Post-approval studies (Phase 4)Study completedNCT03038152
What this trial is testing

Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery

Who this might be right for
Breast Carcinoma Metastatic in Lymph NodeStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7+3 more
M.D. Anderson Cancer Center 54
Early research (Phase 1)Active Not RecruitingNCT03317405
What this trial is testing

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

Who this might be right for
Breast Carcinoma In SituBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In Situ+10 more
National Cancer Institute (NCI) 32
Large-scale testing (Phase 3)Study completedNCT01275677
What this trial is testing

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

Who this might be right for
HER2/Neu PositiveProgesterone Receptor PositiveRecurrent Breast Carcinoma+6 more
National Cancer Institute (NCI) 3,270
Testing effectiveness (Phase 2)Active Not RecruitingNCT02754752
What this trial is testing

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

Who this might be right for
Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+7 more
M.D. Anderson Cancer Center 111
Not applicableActive Not RecruitingNCT02079662
What this trial is testing

The Role of Lifestyle Factors in Breast Cancer-Related Outcomes

Who this might be right for
Stage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7+4 more
M.D. Anderson Cancer Center 110
Not applicableActive Not RecruitingNCT02276443
What this trial is testing

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+9 more
M.D. Anderson Cancer Center 798
Testing effectiveness (Phase 2)Study completedNCT03094052
What this trial is testing

Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib

Who this might be right for
HER2-positive Breast CancerBreast AdenocarcinomaStage II Breast Cancer AJCC v6 and v7+6 more
University of California, San Francisco 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT01266642
What this trial is testing

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast Cancer AJCC v6+5 more
M.D. Anderson Cancer Center 301
Large-scale testing (Phase 3)Study completedNCT03324802
What this trial is testing

Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery

Who this might be right for
Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+4 more
Mayo Clinic 107
Not applicableStudy completedNCT03568526
What this trial is testing

Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer

Who this might be right for
Peripheral NeuropathyStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
Ohio State University Comprehensive Cancer Center 36
Not applicableStudy completedNCT03319342
What this trial is testing

Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors

Who this might be right for
Cancer SurvivorStage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7+6 more
Jonsson Comprehensive Cancer Center 133
Not applicableStudy completedNCT03233555
What this trial is testing

Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer

Who this might be right for
Stage I Breast CancerStage I Colorectal Cancer AJCC v6 and v7Stage I Prostate Cancer+16 more
Rutgers, The State University of New Jersey 535
Load More Results